SCAI

This channel contains news about the Society for Cardiac Angiography and Interventions (SCAI), including coverage of its annual meeting and links to recently released practice guidelines. SCAI is a leading resource in interventional cardiology and cath lab techniques and technologies. 
 

COVID-19 Positive STEMI Patients Have Higher Mortality, First data presented at #TCT2020 on COVID heart attack patients.

Getty Images

News | Coronavirus (COVID-19) | October 14, 2020
October 14, 2020 – The first outcomes data from the North American COVID-19 ST-Segment Elevation Myocardial Infarction...
A panel discussion with some of the key opinion leaders at the recent SCCT 2020 virtual meeting. Note the questions on the left side of the screen, where attendees were able to interact with the speakers. #SCCT2020 #yesCCT

A panel discussion with some of the key opinion leaders at the recent SCCT 2020 virtual meeting. Note the questions on the left side of the screen, where attendees were able to interact with the speakers.

News | Cardiovascular Education | August 14, 2020 | Dave Fornell, Editor
All medical conferences moved to a virtual meeting format due to COVID-19 this year, and there has been apprehension...
 At Mayo, they have a small, tableside-mounted ultrasound console in the cath labs that is used for both radial and femoral vascular access. Table set up with the patient includes a sterile marker, a hemostat for marking the lower edge of the femoral head using fluoroscopy, a micropunture needle, and a still micropunture sheath.

At Mayo, they have a small, tableside-mounted ultrasound console in the cath labs that is used for both radial and femoral vascular access. Table set up with the patient includes a sterile marker, a hemostat for marking the lower edge of the femoral head using fluoroscopy, a micropunture needle and a still micropunture sheath. Photo and slides courtesy of Yader Sandoval, M.D.

Feature | Vascular Access | June 10, 2020 | Dave Fornell, Editor
Vascular access site bleeding is associated with higher complications and mortality rates. For decades femoral access...
Societies Issue Guide to Safely Resume Cardiovascular Procedures, Diagnostic Tests. #COVID19 #SARScov2
Feature | Cardiovascular Business | June 03, 2020
The American College of Cardiology (ACC) together with other North American cardiovascular societies issued a framework...
New Data Confirms Majority of Americans Avoiding Treatment for Heart Attack and Stroke Due to COVID-19. Physio-Control LifePak defibrillator monitor.
Feature | Coronavirus (COVID-19) | May 29, 2020
May 29, 2020 — As states begin to re-open as the number of COVID-19 patients declines, 40 percent of Americans still...
SCAI Announces 2020 Late-breaking Clinical Studies, featured clinical research sessions. #SCAI2020
Feature | SCAI | May 21, 2020
May 21, 2020 — Here is the list of late-breaking study presentations and links to articles about each of them from the...
Left, the Melody pulmonary valve was the first transcatheter valve to be approved by the FDA in the United States a decade ago. Right, the Harmony transcatheter valve is in trials and is designed to treat patients with RVOT anomalies who develop severe PR typically when a pervious repair fails. Both valves are used to treat congenital heart defects. #SCAI #SCAI2020

Left, the Melody pulmonary valve was the first transcatheter valve to be approved by the FDA in the United States a decade ago. Right, the Harmony transcatheter valve is in trials and is designed to treat patients with RVOT anomalies who develop severe PR typically when a pervious repair fails. Both valves are used to treat congenital heart defects.

News | Congenital Heart | May 21, 2020
May 21, 2020 — Two late-breaking clinical trials on trans catheter valves to treat congenital heart disease were...
Patients undergoing cardiac catheterization are traditionally instructed to follow nothing by mouth, or nil per os (NPO), as there are no current standardized fasting protocols, but the CHOWNOW study found patients do not need to fast and will have similar outcomes. #SCAI2020
Feature | Cath Lab | May 18, 2020
May 18, 2020 – Patients undergoing cardiac catheterization are traditionally instructed to follow nothing by mouth, or...
ISCHEMIA Trial: Patients With Intermediate Left Main Coronary Disease Have Worse Cardiovascular Events. #SCAI2020
News | SCAI | May 17, 2020
May 17, 2020 – A new study shows that when compared with patients without intermediate left main coronary artery...
CD34+ Stem Cell Therapy Improved Quality of Life in Patients with Microvascular Dysfunction. #SCAI2020
News | May 17, 2020
May 17, 2020 – Trial results presented today revealed a promising therapy for patients experiencing angina due to...
Icosapent Ethyl (Vascepa) significantly Reduces Revascularizations in Statin Patients in the REDUCE-IT REVASC analyses presented as a late-breaking study at SCAI 2020. Photo by Dave Fornell

Icosapent Ethyl (Vascepa) significantly reduces revascularizations in statin patients based on data from the REDUCE-IT REVASC analyses, presented as a late-breaking study at SCAI 2020. Photo by Dave Fornell

News | Pharmaceuticals | May 17, 2020
May 17, 2020 – Patients with high lipid levels have an increased risk for ischemic events, despite statin therapy....
The Boston Scientific Synergy stent uses a unique abluminal, bioresorbable drug-carrier polymer that dissolves after the vessel wall has healed months after the stent is implanted. Stent polymers have been implicated in cases of late-stent thrombosis, which required patients with DES to stay on dual antiplatelet therapy (DAPT). This study looked at using the device as a way to shorten DAPT duration. #SCAI2020

The Boston Scientific Synergy stent uses a unique abluminal, bioresorbable drug-carrier polymer that dissolves after the vessel wall has healed months after the stent is implanted. Stent polymers have been implicated in cases of late-stent thrombosis, which required patients with DES to stay on dual antiplatelet therapy (DAPT). This study looked at using the device as a way to shorten DAPT duration.

News | Stents | May 17, 2020
May 17, 2020 – A new study sought to reveal whether drug-eluting stents (DES) coated with bioabsorbable polymer (BP)...
Cindy Grines Becomes SCAI President in 2020. #SCAI2020
News | SCAI | May 17, 2020
May 17, 2020 — Cindy Grines, M.D., MSCAI, a world-renowned physician credited for pioneering percutaneous coronary...
The protocol chart for the LATIN STEMI telecardiology program.

The protocol chart for the LATIN STEMI telecardiology program.

News | Telecardiology | May 15, 2020
May 15, 2020 – A groundbreaking trial recently examined the viability of telemedicine for remote guidance of a...
An OCT intracoronary image showing instent restenosis. The white spots in the vessel wall casting shadows are the stent struts. OCT image data might be used in the future to assess FFR to determine the severity of lesions and determine if they need to be stented.

An OCT intracoronary image showing instent restenosis. The white spots in the vessel wall casting shadows are the stent struts. OCT image data might be used in the future to assess FFR to determine the severity of lesions and determine if they need to be stented.

News | FFR Technologies | May 15, 2020
May 15, 2020 – A late-breaking study aimed to evaluate whether optical coherence tomography (OCT) can predict...